2021 Q1 Form 10-Q Financial Statement

#000143774921013178 Filed on May 24, 2021

View on sec.gov

Income Statement

Concept 2021 Q1
Revenue $390.0K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $224.8K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $297.0K
YoY Change
% of Gross Profit
Operating Expenses $1.727M
YoY Change
Operating Profit $4.421M
YoY Change
Interest Expense $459.0K
YoY Change
% of Operating Profit 10.38%
Other Income/Expense, Net
YoY Change
Pretax Income $4.430M
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$2.046M
YoY Change
Net Earnings / Revenue -524.62%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 0.000
Diluted Shares Outstanding 0.000

Balance Sheet

Concept 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $139.6M
YoY Change
Cash & Equivalents $23.39M
Short-Term Investments $138.7M
Other Short-Term Assets $391.7K
YoY Change
Inventory
Prepaid Expenses $391.7K
Receivables
Other Receivables
Total Short-Term Assets $140.0M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets -$1.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $140.0M
Total Long-Term Assets -$1.00
Total Assets $140.0M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $125.6K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.885M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $13.36M
YoY Change
Total Long-Term Liabilities $13.36M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.885M
Total Long-Term Liabilities $13.36M
Total Liabilities $18.24M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$16.95M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$16.95M
YoY Change
Total Liabilities & Shareholders Equity $140.0M
YoY Change

Cashflow Statement

Concept 2021 Q1
OPERATING ACTIVITIES
Net Income -$2.046M
YoY Change
Depreciation, Depletion And Amortization $297.0K
YoY Change
Cash From Operating Activities -$1.272M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $10.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$17.34K
YoY Change
Cash From Investing Activities -$1.273M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $25.86M
YoY Change
NET CHANGE
Cash From Operating Activities -$1.272M
Cash From Investing Activities -$1.273M
Cash From Financing Activities $25.86M
Net Change In Cash $23.32M
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$1.272M
Capital Expenditures $10.00K
Free Cash Flow -$1.282M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001823587
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Yellowstone Acquisition Co
CY2021Q1 dei Entity Shell Company
EntityShellCompany
true
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Security12b Title
Security12bTitle
Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one redeemable warrant
CY2021Q1 dei Trading Symbol
TradingSymbol
ysac
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
125629
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
153928
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
CY2021Q1 us-gaap Assets
Assets
139997369
CY2020Q4 us-gaap Assets
Assets
140241606
CY2021Q1 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
138730613
CY2020Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
138716226
CY2021Q1 us-gaap Cash
Cash
875049
CY2020Q4 us-gaap Cash
Cash
1122194
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1122194
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
875049
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-247145
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4646151
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-style: italic;">Concentration of Credit Risk</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, <div style="display: inline; font-style: italic; font: inherit;"> may </div>exceed the Federal Depository Insurance Coverage of <div style="display: inline; font-style: italic; font: inherit;">$250,000.</div> At <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021, </div>the Company has <div style="display: inline; font-style: italic; font: inherit;">not</div> experienced losses on these accounts and management believes the Company is <div style="display: inline; font-style: italic; font: inherit;">not</div> exposed to significant risks on such accounts.</div></div></div></div></div></div>
CY2021Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
13357690
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
18003841
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
73569
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4430213
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-28299
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-11479
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
CY2021Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
11813
CY2021Q1 us-gaap Liabilities
Liabilities
18242934
CY2020Q4 us-gaap Liabilities
Liabilities
22917384
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
139997369
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
140241606
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4885244
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4913543
CY2021Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-2948
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17335
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-229810
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
4430213
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4421348
CY2021Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
416180678
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
391707
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
403186
CY2021Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
416163343
CY2021Q1 us-gaap Professional Fees
ProfessionalFees
101234
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16954665
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21384878
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-16954325
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-21384538
CY2020Q4 ysac Equity Issued During Period Price Per Unit
EquityIssuedDuringPeriodPricePerUnit
10.20
ysac Maximum Dissolution Expenses Failure To Complete Business Combination
MaximumDissolutionExpensesFailureToCompleteBusinessCombination
100000
CY2021Q1 ysac Percentage Of Shares Mandatorily Redeemed If Fail To Complete Business Combination
PercentageOfSharesMandatorilyRedeemedIfFailToCompleteBusinessCombination
1
CY2021Q1 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
50000
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires the Company's management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div>
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2021Q1 ysac Business Combination Minimum Percentage Of Voting Interest Acquired
BusinessCombinationMinimumPercentageOfVotingInterestAcquired
0.5
ysac Business Combination Period From Ipo For Mandatory Combination
BusinessCombinationPeriodFromIpoForMandatoryCombination
P1Y90D
CY2021Q1 ysac Business Combination Required Fair Market Value Percentage Of Net Assets Held In Trust Account
BusinessCombinationRequiredFairMarketValuePercentageOfNetAssetsHeldInTrustAccount
0.8
CY2021Q1 ysac Business Combination Required Net Tangible Assets
BusinessCombinationRequiredNetTangibleAssets
5000001
CY2021Q1 ysac Common Stock Voting Rights Per Share
CommonStockVotingRightsPerShare
1
CY2021Q1 ysac Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
4759615
CY2020Q4 ysac Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
4759615
CY2021Q1 ysac Stock Redeemed Maximum Percentage Of Outstanding Shares
StockRedeemedMaximumPercentageOfOutstandingShares
0.15
CY2021Q1 ysac Underwriting Agreement Cash Underwriting Discount Aggregate Amount
UnderwritingAgreementCashUnderwritingDiscountAggregateAmount
2500000
CY2021Q1 ysac Underwriting Agreement Cash Underwriting Discount Aggregate Amount Including Underwriter Shares
UnderwritingAgreementCashUnderwritingDiscountAggregateAmountIncludingUnderwriterShares
4759615
CY2021Q1 ysac Underwriting Agreement Cash Underwriting Discount Per Unit
UnderwritingAgreementCashUnderwritingDiscountPerUnit
0.20
CY2021Q1 ysac Underwriting Agreement Deferred Fee Per Unit
UnderwritingAgreementDeferredFeePerUnit
0.35

Files In Submission

Name View Source Status
0001437749-21-013178-index-headers.html Edgar Link pending
0001437749-21-013178-index.html Edgar Link pending
0001437749-21-013178.txt Edgar Link pending
0001437749-21-013178-xbrl.zip Edgar Link pending
ex_240097.htm Edgar Link pending
ex_240098.htm Edgar Link pending
ex_240099.htm Edgar Link pending
ex_240100.htm Edgar Link pending
ex_240101.htm Edgar Link pending
ex_240102.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ysac-20210331.xml Edgar Link completed
ysac-20210331.xsd Edgar Link pending
ysac-20210331_cal.xml Edgar Link unprocessable
ysac-20210331_def.xml Edgar Link unprocessable
ysac-20210331_lab.xml Edgar Link unprocessable
ysac-20210331_pre.xml Edgar Link unprocessable
ysac20210331_10q.htm Edgar Link pending